Checked
Pacific Biosciences of California, Inc.
Nasdaq: PACB · Laboratory Analytical Instruments · Menlo Park, CA
- Revenue
- $160M
- +3.9% vs. prior year
- Net income
- -$546.4M
- -341.5% net margin
- Total assets
- $784.1M
- Diluted EPS
- -$1.82
Company details
As reported to the SEC
- SEC CIK
- 1299130
- Stock
- Nasdaq: PACB
- Legal Entity Identifier (LEI)
- 529900F1BWRE1M0KZN89
- Industry (SIC)
- Laboratory Analytical Instruments (3826)
- Headquarters
- 1305 O'Brien Drive, Menlo Park, CA 94025
- Incorporated in
- Delaware
- Fiscal year end (SEC record)
- December 31
- Filer status
- Accelerated filer
- Phone
- (650) 521-8000
- Employer ID (EIN)
- 16-1590339
- Last annual report
- 02/25/2026
- Last quarterly report
- 08/06/2026
Formerly: PACIFIC BIOSCIENCES OF CALIFORNIA INC (until 02/05/2013); NANOFLUIDICS INC (until 07/28/2004)
Annual financials
U.S. dollars, as tagged in each annual report's XBRL data. Later restatements replace earlier numbers. Select a date to open the filing.
| Fiscal year ended | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 |
|---|---|---|---|---|---|
| Revenue | $160M | $154M | $200.5M | $128.3M | $130.5M |
| Gross profit | $45.78M | $37.28M | $52.78M | $49.03M | $58.86M |
| Operating income | -$553.9M | -$474.3M | -$334.5M | -$307.2M | -$210.4M |
| Net income | -$546.4M | -$309.9M | -$306.7M | -$314.2M | -$181.2M |
| Diluted earnings per share | -$1.82 | -$1.59 | -$1.21 | -$1.40 | -$0.89 |
| Research and development | $97.31M | $134.9M | $187.2M | $193M | $112.9M |
| Total assets | $784.1M | $1.26B | $1.75B | $1.77B | $2.01B |
| Total liabilities | $778.7M | $753.9M | $1.04B | $1.2B | $1.22B |
| Shareholders' equity | $5.35M | $506.6M | $701.3M | $562.9M | $791M |
| Cash and cash equivalents | $63.71M | $55.37M | $179.9M | $325.1M | $460.7M |
| Long-term debt | Not reported | Not reported | Not reported | $896.7M | $896.1M |
| Cash from operations | -$111.2M | -$206.1M | -$259.2M | -$263.2M | -$111.2M |
| Capital expenditures | $2.71M | $6.19M | $8.84M | $16.75M | $5.93M |
Federal and state records filed under the name Pacific Biosciences of California, Inc.
Matched by the company name and by the subsidiary names it lists in SEC filings and other public records, after removing endings like Inc., Corp. and Holdings. Records marked Subsidiary were filed under a subsidiary name. A subsidiary that is not listed in those records is not included, and an unrelated business with the same name can appear.
Work visa sponsorship
Certified H-1B and PERM green card filings with the Department of Labor
| Employer on filing | H-1B | PERM |
|---|---|---|
| Pacific Biosciences of California, Inc.Menlo Park, CA | 8 | 1 |
Subsidiaries
12 companies that Pacific Biosciences of California, Inc. owns or controls, as listed in its SEC annual report (Exhibit 21), GLEIF ownership records or USAspending
| Subsidiary | Listed in |
|---|---|
| Apton Biosystems LLC | SEC 10-K |
| Circulomics Inc. | SEC 10-K |
| Omniome, LLC | SEC 10-K |
| PacBio B.V. | SEC 10-K |
| PacBio Singapore Pte. Limited | SEC 10-K |
| PacBio of Korea, Yuhan Hoesa | SEC 10-K |
| Pacific Biosciences (Shanghai) Co., Ltd. | SEC 10-K |
| Pacific Biosciences Canada Limited | SEC 10-K |
| Pacific Biosciences Germany GmbH | SEC 10-K |
| Pacific Biosciences International LLC | SEC 10-K |
| Pacific Biosciences Japan GK | SEC 10-K |
| Pacific Biosciences UK, Ltd. | SEC 10-K |
Recent filings
143 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here
Swipe the table sideways to see more columns.
32 insider ownership reports (Forms 3, 4, 5 and 144) were filed about Pacific Biosciences of California, Inc. in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.
Other laboratory analytical instruments
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| Agilent Technologies, Inc.A | Santa Clara, CA | $6.95B | $1.3B |
| Avantor, Inc.AVTR | Radnor, PA | $6.55B | -$530.2M |
| Illumina, Inc.ILMN | San Diego, CA | $4.34B | $850M |
| Mettler Toledo International Inc/MTD | Columbus, OH | $4.03B | $869.2M |
| Bruker CorpBRKR | Billerica, MA | $3.44B | -$8.6M |
| Waters CorpWAT | Milford, MA | $3.17B | $642.6M |
| Revvity, Inc.RVTY | Waltham, MA | $2.86B | $241.2M |
| Bio-Rad Laboratories, Inc.BIO | Hercules, CA | $2.58B | $759.9M |
Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.
Frequently asked questions
- What is Pacific Biosciences of California, Inc.'s CIK number?
- Pacific Biosciences of California, Inc.'s SEC Central Index Key (CIK) is 1299130.
- What is Pacific Biosciences of California, Inc.'s stock ticker?
- Pacific Biosciences of California, Inc. trades as Nasdaq: PACB.
- What was Pacific Biosciences of California, Inc.'s revenue?
- Pacific Biosciences of California, Inc. reported revenue of $160M for the fiscal year ended Dec 31, 2025, +3.9% from the year before.
- When does Pacific Biosciences of California, Inc.'s fiscal year end?
- Pacific Biosciences of California, Inc.'s fiscal year end on file with the SEC is December 31; its most recent fiscal year ended Dec 31, 2025.
- Where is Pacific Biosciences of California, Inc. headquartered?
- Pacific Biosciences of California, Inc.'s principal executive office on file with the SEC is in Menlo Park, CA.
- What companies does Pacific Biosciences of California, Inc. own?
- Pacific Biosciences of California, Inc. lists 12 subsidiaries in its SEC filings and other public records, including Apton Biosystems LLC, Circulomics Inc., Omniome, LLC.
- Does Pacific Biosciences of California, Inc. sponsor H-1B visas?
- Department of Labor records show 8 certified H-1B filings and 1 certified PERM filings under the name Pacific Biosciences of California, Inc.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026